Business · 1 sources covering this

Sun Pharma Q2 net profit falls 36% on one-time charges, revenue rises 12%

Exceptional charges of Rs 1,268.8 crore, including a US antitrust settlement and Organon acquisition costs, weighed on profit, while India formulation sales grew 17.3 per cent

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·2h ago
Sun Pharma Q2 net profit falls 36% on one-time charges, revenue rises 12%
Exceptional charges of Rs 1,268.8 crore, including a US antitrust settlement and Organon acquisition costs, weighed on profit, while India formulation sales grew 17.3 per cent
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/f7f535fa1e5a2afc3bdc1f417711662393ff6404"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Sun Pharma Q2 net profit falls 36% on one-time charges, revenue rises 12%"></iframe>

Sun Pharma Q2 net profit falls 36% on one-time charges, revenue rises 12%

How 1 sources are covering this

Sun Pharma Q2 net profit falls 36% on one-time charges, revenue rises 12%

More from Business

IOC Q2 profit soars 184% on higher refining margins

India slashed U.S. and Russian oil in September, coinciding with ‘Russia Sanctions Act’; import from UAE increases

Govt names 1993-batch IAS officer Poundrik as heavy industries secretary

FM cites World Bank poverty gains, says govt committed to inclusive growth

Reader

Trust & legal

Across the network